FDA Shows Confidence in Pfizer’s Maternal RSV Shot Ahead of Panel

Abrysvo, Pfizer’s investigational vaccine for respiratory syncytial virus infection, appears to be safe and effective in the pediatric setting, according to the FDA’s briefing document published ahead of an advisory committee meeting.